# Regal Rexnord Corp: financial statements, quarterly

RRX · NYSE · CIK 82811 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rrx.md) · [Financials](/companies/rrx/financials.md) · [Filings](/companies/rrx/filings.md) · [Insiders](/companies/rrx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rrx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,650](/filings/0000082811-23-000190.md) | [1,608 d](/filings/0000082811-24-000035.md) | [1,548](/filings/0000082811-24-000088.md) | [1,548](/filings/0000082811-24-000163.md) | [1,477](/filings/0000082811-25-000215.md) | [1,461 d](/filings/0000082811-26-000054.md) | [1,418](/filings/0000082811-26-000144.md) | [1,496](/filings/0000082811-26-000229.md) | [1,497](/filings/0000082811-25-000215.md) | [1,523 d](/filings/0000082811-26-000054.md) | [1,479](/filings/0000082811-26-000144.md) | [1,558](/filings/0000082811-26-000229.md) |
| Cost of revenue | $m | [1,108](/filings/0000082811-24-000210.md) | [1,045 d](/filings/0000082811-26-000054.md) | [995](/filings/0000082811-25-000119.md) | [977](/filings/0000082811-25-000202.md) | [921](/filings/0000082811-25-000215.md) | [951 d](/filings/0000082811-26-000054.md) | [891](/filings/0000082811-26-000144.md) | [931](/filings/0000082811-26-000229.md) | [943](/filings/0000082811-25-000215.md) | [952 d](/filings/0000082811-26-000054.md) | [929](/filings/0000082811-26-000144.md) | [947](/filings/0000082811-26-000229.md) |
| Gross profit | $m | [542](/filings/0000082811-24-000210.md) | [563 d](/filings/0000082811-26-000054.md) | [553](/filings/0000082811-25-000119.md) | [571](/filings/0000082811-25-000202.md) | [556](/filings/0000082811-25-000215.md) | [511 d](/filings/0000082811-26-000054.md) | [528](/filings/0000082811-26-000144.md) | [565](/filings/0000082811-26-000229.md) | [554](/filings/0000082811-25-000215.md) | [571 d](/filings/0000082811-26-000054.md) | [550](/filings/0000082811-26-000144.md) | [612](/filings/0000082811-26-000229.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(20.4)](/filings/0000082811-24-000210.md) | [177 d](/filings/0000082811-26-000054.md) | [134](/filings/0000082811-25-000119.md) | [194](/filings/0000082811-25-000202.md) | [174](/filings/0000082811-25-000215.md) | [128 d](/filings/0000082811-26-000054.md) | [160](/filings/0000082811-26-000144.md) | [182](/filings/0000082811-26-000229.md) | [174](/filings/0000082811-25-000215.md) | [165 d](/filings/0000082811-26-000054.md) | [153](/filings/0000082811-26-000144.md) | [215](/filings/0000082811-26-000229.md) |
| Interest expense | $m | [112](/filings/0000082811-23-000190.md) | [108 d](/filings/0000082811-24-000035.md) | [105](/filings/0000082811-24-000088.md) | [102](/filings/0000082811-25-000202.md) | [98.0](/filings/0000082811-25-000215.md) | [94.6 d](/filings/0000082811-26-000054.md) | [90.2](/filings/0000082811-26-000144.md) | [85.3](/filings/0000082811-26-000229.md) | [87.0](/filings/0000082811-25-000215.md) | [86.7 d](/filings/0000082811-26-000054.md) | [80.5](/filings/0000082811-26-000144.md) | [77.4](/filings/0000082811-26-000229.md) |
| Income tax | $m | [12.7](/filings/0000082811-24-000210.md) | [17.8 d](/filings/0000082811-26-000054.md) | [10.9](/filings/0000082811-25-000119.md) | [33.9](/filings/0000082811-25-000202.md) | [8.4](/filings/0000082811-25-000215.md) | [(3.6) d](/filings/0000082811-26-000054.md) | [15.5](/filings/0000082811-26-000144.md) | [21.6](/filings/0000082811-26-000229.md) | [11.9](/filings/0000082811-25-000215.md) | [22.7 d](/filings/0000082811-26-000054.md) | [12.2](/filings/0000082811-26-000144.md) | [26.9](/filings/0000082811-26-000229.md) |
| Net income | $m | [(140)](/filings/0000082811-24-000210.md) | [55.9 d](/filings/0000082811-26-000054.md) | [19.8](/filings/0000082811-25-000119.md) | [62.5](/filings/0000082811-25-000202.md) | [72.7](/filings/0000082811-25-000215.md) | [41.2 d](/filings/0000082811-26-000054.md) | [57.3](/filings/0000082811-26-000144.md) | [79.2](/filings/0000082811-26-000229.md) | [79.6](/filings/0000082811-25-000215.md) | [63.6 d](/filings/0000082811-26-000054.md) | [64.3](/filings/0000082811-26-000144.md) | [117](/filings/0000082811-26-000229.md) |
| Diluted EPS | $ per share | [(2.10)](/filings/0000082811-24-000210.md) | not reported | [0.30](/filings/0000082811-25-000119.md) | [0.94](/filings/0000082811-25-000202.md) | [1.09](/filings/0000082811-25-000215.md) | not reported | [0.86](/filings/0000082811-26-000144.md) | [1.19](/filings/0000082811-26-000229.md) | [1.20](/filings/0000082811-25-000215.md) | not reported | [0.96](/filings/0000082811-26-000144.md) | [1.74](/filings/0000082811-26-000229.md) |
| Basic EPS | $ per share | [(2.10)](/filings/0000082811-24-000210.md) | not reported | [0.30](/filings/0000082811-25-000119.md) | [0.94](/filings/0000082811-25-000202.md) | [1.09](/filings/0000082811-25-000215.md) | not reported | [0.86](/filings/0000082811-26-000144.md) | [1.19](/filings/0000082811-26-000229.md) | [1.20](/filings/0000082811-25-000215.md) | not reported | [0.97](/filings/0000082811-26-000144.md) | [1.75](/filings/0000082811-26-000229.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.5](/filings/0000082811-24-000210.md) | [0.6](/filings/0000082811-25-000046.md) | [0.5](/filings/0000082811-24-000088.md) | [0.5](/filings/0000082811-24-000163.md) | [0.5](/filings/0000082811-24-000210.md) | [0.4](/filings/0000082811-26-000054.md) | [0.3](/filings/0000082811-25-000119.md) | [0.3](/filings/0000082811-25-000202.md) | [0.4](/filings/0000082811-25-000215.md) | [0.5](/filings/0000082811-26-000229.md) | [0.4](/filings/0000082811-26-000144.md) | [0.4](/filings/0000082811-26-000229.md) |
| Current assets | $bn | [3.4](/filings/0000082811-23-000190.md) | [3.4](/filings/0000082811-25-000046.md) | [3.3](/filings/0000082811-24-000088.md) | [3.0](/filings/0000082811-24-000163.md) | [3.0](/filings/0000082811-24-000210.md) | [2.8](/filings/0000082811-26-000054.md) | [2.8](/filings/0000082811-25-000119.md) | [2.5](/filings/0000082811-25-000202.md) | [2.6](/filings/0000082811-25-000215.md) | [2.7](/filings/0000082811-26-000229.md) | [2.7](/filings/0000082811-26-000144.md) | [2.8](/filings/0000082811-26-000229.md) |
| Total assets | $bn | [15.4](/filings/0000082811-23-000190.md) | [15.4](/filings/0000082811-25-000046.md) | [15.1](/filings/0000082811-24-000088.md) | [14.6](/filings/0000082811-24-000163.md) | [14.6](/filings/0000082811-24-000210.md) | [14.0](/filings/0000082811-26-000054.md) | [14.0](/filings/0000082811-25-000119.md) | [13.9](/filings/0000082811-25-000202.md) | [13.9](/filings/0000082811-25-000215.md) | [13.9](/filings/0000082811-26-000229.md) | [13.8](/filings/0000082811-26-000144.md) | [13.8](/filings/0000082811-26-000229.md) |
| Current liabilities | $bn | [1.3](/filings/0000082811-23-000190.md) | [1.3](/filings/0000082811-25-000046.md) | [1.2](/filings/0000082811-24-000088.md) | [1.2](/filings/0000082811-24-000163.md) | [1.2](/filings/0000082811-24-000210.md) | [1.2](/filings/0000082811-26-000054.md) | [1.2](/filings/0000082811-25-000119.md) | [1.3](/filings/0000082811-25-000202.md) | [1.3](/filings/0000082811-25-000215.md) | [1.3](/filings/0000082811-26-000229.md) | [1.3](/filings/0000082811-26-000144.md) | [1.2](/filings/0000082811-26-000229.md) |
| Long-term debt | $bn | [6.5](/filings/0000082811-23-000190.md) | [6.4](/filings/0000082811-25-000046.md) | [6.2](/filings/0000082811-24-000088.md) | [5.8](/filings/0000082811-24-000163.md) | [5.7](/filings/0000082811-24-000210.md) | [5.5](/filings/0000082811-26-000054.md) | [5.3](/filings/0000082811-25-000119.md) | [4.8](/filings/0000082811-25-000202.md) | [4.8](/filings/0000082811-25-000215.md) | [4.8](/filings/0000082811-26-000229.md) | [4.7](/filings/0000082811-26-000144.md) | [4.6](/filings/0000082811-26-000229.md) |
| Current portion of debt | $bn | [0.0](/filings/0000082811-23-000190.md) | [0.0](/filings/0000082811-25-000046.md) | [0.0](/filings/0000082811-24-000088.md) | [0.0](/filings/0000082811-24-000163.md) | [0.0](/filings/0000082811-24-000210.md) | [0.0](/filings/0000082811-26-000054.md) | [0.0](/filings/0000082811-25-000119.md) | [0.0](/filings/0000082811-25-000202.md) | [0.0](/filings/0000082811-25-000215.md) | [0.0](/filings/0000082811-26-000229.md) | [0.0](/filings/0000082811-26-000144.md) | [0.0](/filings/0000082811-26-000229.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [6.2](/filings/0000082811-23-000190.md) | [6.3](/filings/0000082811-25-000046.md) | [6.3](/filings/0000082811-24-000088.md) | [6.4](/filings/0000082811-24-000163.md) | [6.5](/filings/0000082811-24-000210.md) | [6.3](/filings/0000082811-26-000054.md) | [6.4](/filings/0000082811-25-000119.md) | [6.7](/filings/0000082811-25-000202.md) | [6.8](/filings/0000082811-25-000215.md) | [6.8](/filings/0000082811-26-000229.md) | [6.8](/filings/0000082811-26-000144.md) | [6.9](/filings/0000082811-26-000229.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [187 d](/filings/0000082811-24-000210.md) | [201 d](/filings/0000082811-26-000054.md) | [83.1](/filings/0000082811-25-000119.md) | [158 d](/filings/0000082811-25-000202.md) | [155 d](/filings/0000082811-25-000215.md) | [213 d](/filings/0000082811-26-000054.md) | [102](/filings/0000082811-26-000144.md) | [523 d](/filings/0000082811-26-000229.md) | [198 d](/filings/0000082811-25-000215.md) | [168 d](/filings/0000082811-26-000054.md) | [14.9](/filings/0000082811-26-000144.md) | [177 d](/filings/0000082811-26-000229.md) |
| Capital expenditure | $m | [25.2](/filings/0000082811-23-000190.md) | [30.4 d](/filings/0000082811-26-000054.md) | [18.5](/filings/0000082811-25-000119.md) | [32.4 d](/filings/0000082811-25-000202.md) | [29.3 d](/filings/0000082811-25-000215.md) | [29.3 d](/filings/0000082811-26-000054.md) | [16.8](/filings/0000082811-26-000144.md) | [30.2 d](/filings/0000082811-26-000229.md) | [23.5 d](/filings/0000082811-25-000215.md) | [27.2 d](/filings/0000082811-26-000054.md) | [17.4](/filings/0000082811-26-000144.md) | [22.5 d](/filings/0000082811-26-000229.md) |
| Dividends paid | $m | [23.2 d](/filings/0000082811-24-000210.md) | [23.2 d](/filings/0000082811-26-000054.md) | [23.3](/filings/0000082811-25-000119.md) | [23.3 d](/filings/0000082811-25-000202.md) | [23.3 d](/filings/0000082811-25-000215.md) | [23.1 d](/filings/0000082811-26-000054.md) | [23.2](/filings/0000082811-26-000144.md) | [23.4 d](/filings/0000082811-26-000229.md) | [23.1 d](/filings/0000082811-25-000215.md) | [23.3 d](/filings/0000082811-26-000054.md) | [23.3](/filings/0000082811-26-000144.md) | [23.3 d](/filings/0000082811-26-000229.md) |
| Share repurchases | $m | [0.0 d](/filings/0000082811-24-000210.md) | [0.0 d](/filings/0000082811-26-000054.md) | not reported | not reported | not reported | [0.0 d](/filings/0000082811-26-000054.md) | not reported | not reported | not reported | [0.0 d](/filings/0000082811-26-000054.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [66.7](/filings/0000082811-23-000190.md) | [66.6](/filings/0000082811-24-000088.md) | [66.6](/filings/0000082811-24-000163.md) | [66.3](/filings/0000082811-24-000210.md) | [66.8](/filings/0000082811-25-000119.md) | [66.8](/filings/0000082811-25-000202.md) | [66.7](/filings/0000082811-25-000215.md) | [66.5](/filings/0000082811-26-000144.md) | [66.5](/filings/0000082811-26-000229.md) | [66.6](/filings/0000082811-25-000215.md) | [66.8](/filings/0000082811-26-000144.md) | [66.9](/filings/0000082811-26-000229.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 66,591,867 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0000082811-26-000229.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.